A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1997
10/29/1997	EP0802787A1 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use
10/29/1997	EP0773229B1 Cyclodextrin derivatives and their use, especially in cosmetics
10/29/1997	EP0759744A4 Narcotic containing aerosol formulation
10/29/1997	EP0639069B1 Galenic form for ocular administration and process for the preparation of same
10/29/1997	EP0619825B1 A method for preparing enteric-coated oral drugs containing acid-unstable compounds
10/29/1997	CN1163612A Preparation of immunogens and other conjugates of drugs
10/29/1997	CN1163575A Immunogenic compositions
10/29/1997	CN1163563A Liposome composition containing selegilin
10/29/1997	CN1163103A Controlled releasing of steroid from sugarcoating
10/28/1997	US5681855 Prostaglandin e emulsion
10/28/1997	US5681853 Mixture with amphoteric compound
10/28/1997	US5681849 Pharmaceutical composition for topical applications
10/28/1997	US5681846 Extended stability formulations for paclitaxel
10/28/1997	US5681829 Class of phosphocholine derivatives having antifungal activity
10/28/1997	US5681828 Selective alkylations of cyclodextrins leading to derivatives which have a rigidly extended cavity
10/28/1997	US5681827 Aqueous pourable liquid containing low viscosity sodium alginate, potassium bicarbonate
10/28/1997	US5681822 Shelf stable solutions of cladribine in benzyl alcohol
10/28/1997	US5681814 Formulated IGF-I Composition
10/28/1997	US5681812 Methods and compositions for reducing multidrug resistance
10/28/1997	US5681811 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997	US5681582 Extended release, film-coated tablet of astemizole and pseudoephedrine
10/28/1997	US5681577 Multiple action cold/sinus preparations
10/28/1997	US5681573 Dissolving in water saturated with carbon dioxide, then freeze drying the solution yields storage stable drug for injection after regeneration
10/28/1997	US5681571 Immunological tolerance-inducing agent
10/28/1997	US5681568 Device for delivery of substances and methods of use thereof
10/28/1997	US5681567 Method of preparing polyalkylene oxide carboxylic acids
10/28/1997	CA2031656C Alkoxylated alkyl glucoside ether quaternaries useful in personal care
10/25/1997	CA2199920A1 Acetylsalicylic acid-containing alcoholic solutions for percutaneous employment, their use for antithrombotic therapy, and a pharmaceutical
10/24/1997	CA2194428A1 Controlled release of steroids from sugar coatings
10/23/1997	WO1997039134A1 Virus-like particle
10/23/1997	WO1997039050A1 Sustained release heterodisperse hydrogel systems - amorphous drugs
10/23/1997	WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997	WO1997038960A1 D-mannitol and its preparation
10/23/1997	WO1997038731A1 Immunoliposomes that optimize internalization into target cells
10/23/1997	WO1997038729A1 In vivo gene transfer methods for wound healing
10/23/1997	WO1997038727A1 Medicament composite
10/23/1997	WO1997038726A2 Hydrophobic carbomer complex compositions
10/23/1997	WO1997038698A1 Methods for treating middle and inner ear disorders
10/23/1997	WO1997038679A2 Fast disintegrating oral dosage form
10/23/1997	WO1997038675A1 New pharmaceutical composition with anaesthetic effect
10/23/1997	WO1997038674A1 Ophthalmic compound with extended dwell time on the eye
10/23/1997	WO1997038668A1 Local delivery of chemotherapeutic agents for treatment of periodontal disease
10/23/1997	WO1997038663A2 Buccal, non-polar spray or capsule
10/23/1997	WO1997033632A3 Alginate containing antimicrobial composition
10/23/1997	WO1997026918A3 Ligand directed enzyme prodrug therapy
10/23/1997	WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997	WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997	WO1997022368A3 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
10/23/1997	DE19615812A1 Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation Pharmaceutical preparation for oral administration containing diphosphonic acids
10/23/1997	DE19615777A1 Verwendung von Milschsäureestern Use of Milschsäureestern
10/23/1997	DE19615418A1 Polyol-Zusammensetzung Polyol composition
10/23/1997	CA2251849A1 Hydrophobic carbomer complex compositions
10/23/1997	CA2251092A1 D-mannitol and its preparation
10/23/1997	CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/22/1997	EP0801950A1 Pharmaceutical composition for diuretic and antihypertensive oral therapy comprising furosemide and tromethamine
10/22/1997	EP0801948A1 Ophthalmic composition having prolonged residence time in the eye
10/22/1997	EP0801676A2 New artificial tissue, method for the production and the use thereof
10/22/1997	EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997	EP0801571A1 Soluble 2-chloro-2'-deoxyadenosine formulations
10/22/1997	EP0801570A1 Formulations and methods for reducing skin irritation
10/22/1997	EP0801562A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
10/22/1997	EP0801561A2 Composition and methods for transdermal delivery of acid-labile drugs
10/22/1997	EP0801558A1 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
10/22/1997	EP0801554A1 Formulations and methods for reducing skin irritation
10/22/1997	EP0697858B1 Nasal drug delivery composition containing nicotine
10/22/1997	EP0679093B1 Methods of delivering agents to target cells
10/22/1997	EP0672076B1 Use of cationic polyurethanes and polycarbamides as auxiliary substances in cosmetic and pharmaceutical compositions
10/22/1997	EP0228458B2 Epithelial cells expressing foreign genetic material
10/21/1997	US5679809 Concentrate of polyunsaturated fatty acid ethyl esters and preparation thereof
10/21/1997	US5679779 Crosslinked isocyanate-functional polymer supports
10/21/1997	US5679777 Time-release agents comprising conjugates of genetically engineered proteins as drug carriers; enhanced stability; increased vascular retention
10/21/1997	US5679690 Solution consists of antithrombin argatroban, micelle forming agents such as cholic acid derivatives and one or more lipids
10/21/1997	US5679685 Accelerated release composition containing bromocriptine
10/21/1997	US5679660 Pharmaceutical composition comprising diclofenac and cyclodextrin
10/21/1997	US5679653 Diagnosis and treatment of bacterial dystentery
10/21/1997	US5679646 Dissolving the salt prepared with 3-p-methoxybenzylidene-6-hydroxy-4'-methoxyflavanone-6-phosphate in a tetrahydrofuran/water mixture of from 6 to 9.75:4 to 0.25 and loading a carrier; drug delivery; controlled release
10/21/1997	US5679644 Methods of treating diseases using triterpenoid acid derivatives
10/21/1997	US5679637 Fibroblast growth factor conjugates
10/21/1997	US5679573 Oxidation resistance
10/21/1997	US5679559 Cationic polymer and lipoprotein-containing system for gene delivery
10/21/1997	US5679510 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
10/21/1997	US5679394 Adjunct administration of particulate therapeutic or diagnostic agent and dwell-time enhancing agent
10/21/1997	US5679377 Protein microspheres and methods of using them
10/21/1997	US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/21/1997	US5679350 Method of delivery of a medicament to a cancer cell using a pathway of plasminogen activator material
10/21/1997	US5679337 Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
10/21/1997	US5679336 Antibacterial compositions
10/21/1997	US5679328 Improved rheological properties
10/21/1997	US5679287 Uses of heptafluoropropane
10/21/1997	CA1339502C Anti-cancer activity potentiator
10/16/1997	WO1997037690A2 Cytomodulating conjugates of members of specific binding pairs
10/16/1997	WO1997037689A2 Denaturants for sympathomimetic amine salts
10/16/1997	WO1997037680A1 Macromolecular complexes for drug delivery
10/16/1997	WO1997037653A1 Injection formulations of avermectins and milbemycins based on castor oil
10/16/1997	WO1997037642A1 Estradiol and progesterone-based medicament
10/16/1997	WO1997037641A1 Oral coated active drugs
10/16/1997	WO1997037640A2 Uniform drug delivery therapy
10/16/1997	WO1997037639A1 Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose
10/16/1997	WO1997030975A3 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support

1 ... 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 ... 1712